NanoString Technologies Company Profile (NASDAQ:NSTG)

About NanoString Technologies

NanoString Technologies logoNanoString Technologies, Inc. develops and manufactures intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company operates in the segment of development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. It markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology, and to clinical laboratories and medical centers for diagnostic use. Its molecular diagnostic product Prosigna Breast Cancer Assay provides an assessment of a patient's risk of recurrence for breast cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NSTG
  • CUSIP:
Key Metrics:
  • Previous Close: $19.03
  • 50 Day Moving Average: $18.75
  • 200 Day Moving Average: $19.65
  • 52-Week Range: $11.86 - $23.45
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.10
  • P/E Growth: 0.00
  • Market Cap: $395.51M
  • Outstanding Shares: 21,004,000
  • Beta: 1.1
Profitability:
  • Net Margins: -53.02%
  • Return on Equity: -784.63%
  • Return on Assets: -43.90%
Debt:
  • Debt-to-Equity Ratio: -7.17%
  • Current Ratio: 3.14%
  • Quick Ratio: 2.74%
Additional Links:
Companies Related to NanoString Technologies:

Analyst Ratings

Consensus Ratings for NanoString Technologies (NASDAQ:NSTG) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.50 (8.87% upside)

Analysts' Ratings History for NanoString Technologies (NASDAQ:NSTG)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016BTIG ResearchReiterated RatingBuy$20.00View Rating Details
5/8/2016Morgan StanleyReiterated RatingBuyView Rating Details
5/8/2016Robert W. BairdReiterated RatingBuyView Rating Details
3/15/2016Janney Montgomery ScottInitiated CoverageBuy$21.00View Rating Details
1/7/2016Cowen and CompanyLower Price Target$18.00View Rating Details
8/5/2015Leerink SwannReiterated RatingBuy$17.00 -> $19.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for NanoString Technologies (NASDAQ:NSTG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017        
11/2/2016Q316($0.52)($0.51)$23.46 million$23.90 millionViewN/AView Earnings Details
8/3/2016Q2($0.66)($0.55)$19.62 million$22.60 millionViewN/AView Earnings Details
5/5/2016Q1($0.69)($0.74)$14.92 million$14.70 millionViewN/AView Earnings Details
2/29/2016Q4($0.54)($0.44)$21.12 million$22.30 millionViewN/AView Earnings Details
11/2/2015Q315($0.50)($0.49)$15.44 million$15.70 millionViewListenView Earnings Details
8/4/2015Q215($0.57)($0.66)$12.80 million$13.10 millionViewN/AView Earnings Details
5/6/2015Q115($0.58)($0.81)$12.10 million$11.59 millionViewN/AView Earnings Details
2/24/2015Q414($0.53)($0.68)$15.03 million$15.60 millionViewN/AView Earnings Details
11/4/2014Q314($0.56)($0.54)$11.80 million$12.30 millionViewN/AView Earnings Details
8/5/2014Q214($0.65)($0.58)$10.20 million$10.90 millionViewN/AView Earnings Details
5/7/2014Q114($0.76)($0.56)$8.37 million$8.70 millionViewN/AView Earnings Details
2/26/2014Q4($0.89)($0.60)$9.61 million$10.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NanoString Technologies (NASDAQ:NSTG)
Current Year EPS Consensus Estimate: $-2.28 EPS
Next Year EPS Consensus Estimate: $-2.07 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.64)($0.61)($0.63)
Q2 20161($0.68)($0.68)($0.68)
Q3 20161($0.60)($0.60)($0.60)
Q4 20161($0.46)($0.46)($0.46)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NanoString Technologies (NASDAQ:NSTG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NanoString Technologies (NASDAQ:NSTG)
Insider Ownership Percentage: 33.30%
Institutional Ownership Percentage: 86.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/6/2016Wayne BurnsSVPSell21,666$22.04$477,518.64View SEC Filing  
11/21/2016Charles P Waite JrDirectorSell588,024$21.25$12,495,510.00View SEC Filing  
11/11/2016Barney SaundersSVPSell11,983$22.48$269,377.84View SEC Filing  
11/11/2016James A JohnsonCFOSell10,000$22.57$225,700.00View SEC Filing  
11/11/2016R Bradley GrayInsiderSell37,325$22.49$839,439.25View SEC Filing  
10/26/2016Charles P Waite JrDirectorSell42,489$20.56$873,573.84View SEC Filing  
9/8/2016Charles P Waite JrDirectorSell29,105$16.51$480,523.55View SEC Filing  
9/7/2016Wayne BurnsSVPSell3,961$16.50$65,356.50View SEC Filing  
8/30/2016Charles P Waite JrDirectorSell111,060$16.57$1,840,264.20View SEC Filing  
8/25/2016Charles P Waite JrDirectorSell40,363$16.59$669,622.17View SEC Filing  
8/22/2016Charles P Waite JrDirectorSell72,145$16.61$1,198,328.45View SEC Filing  
8/16/2016Charles P Waite JrDirectorSell257,698$16.55$4,264,901.90View SEC Filing  
3/2/2016David W GhesquiereSVPSell1,321$14.86$19,630.06View SEC Filing  
8/13/2015Wayne BurnsSVPSell30,000$14.93$447,900.00View SEC Filing  
12/2/2014Barney SaundersSVPSell30,000$14.93$447,900.00View SEC Filing  
11/14/2014Charles P Waite JrDirectorSell14,632$12.25$179,242.00View SEC Filing  
9/8/2014Charles P Waite JrDirectorSell45,000$11.21$504,450.00View SEC Filing  
9/5/2014Charles P Waite JrDirectorSell86,942$11.17$971,142.14View SEC Filing  
9/3/2014Ovp Venture Partners Vi LpMajor ShareholderSell35,000$11.15$390,250.00View SEC Filing  
8/19/2014Charles P Waite JrDirectorSell1,700$12.01$20,417.00View SEC Filing  
8/19/2014Ovp Venture Partners Vi LpMajor ShareholderSell20,257$12.05$244,096.85View SEC Filing  
8/18/2014Charles P Waite JrDirectorSell18,557$12.05$223,611.85View SEC Filing  
8/18/2014Ovp Venture Partners Vi LpMajor ShareholderSell11,925$12.05$143,696.25View SEC Filing  
8/15/2014Ovp Venture Partners Vi LpMajor ShareholderSell28,801$12.36$355,980.36View SEC Filing  
6/13/2014Charles P Waite JrDirectorSell166,755$15.08$2,514,665.40View SEC Filing  
6/13/2014Wayne BurnsSVPSell4,900$15.01$73,549.00View SEC Filing  
6/12/2014Barney SaundersSVPSell28,000$15.04$421,120.00View SEC Filing  
6/10/2014Ovp Venture Partners Vi LpMajor ShareholderSell160,000$15.48$2,476,800.00View SEC Filing  
6/9/2014Wayne BurnsSVPSell20,100$15.76$316,776.00View SEC Filing  
7/1/2013Lifesciences Ii L.P. ClarusMajor ShareholderBuy750,000$10.00$7,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NanoString Technologies (NASDAQ:NSTG)
DateHeadline
News IconNanoString Technologies Inc NSTG Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:NSTG)
www.bioportfolio.com - February 25 at 8:00 AM
finance.yahoo.com logoNanoString Technologies to Release Fourth Quarter and Fiscal Year 2016 Financial Results and Host Conference Call on Wednesday, March 1, 2017 (NASDAQ:NSTG)
finance.yahoo.com - February 24 at 9:00 AM
4-traders.com logoOcean Rig UDW reports 4Q loss (NASDAQ:NSTG)
www.4-traders.com - February 22 at 7:00 PM
finance.yahoo.com logoNanoString Technologies to Present at the Cowen and Company 37th Annual Health Care Conference (NASDAQ:NSTG)
finance.yahoo.com - February 22 at 7:00 PM
biz.yahoo.com logoNANOSTRING TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:NSTG)
biz.yahoo.com - February 22 at 7:00 PM
News IconNanoString Technologies Inc NSTG Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:NSTG)
www.bioportfolio.com - February 20 at 6:13 PM
us.rd.yahoo.com logoNanoString Highlights Progress on Product Roadmap Featuring Multiple Innovative Technologies at 2017 Advances in Genome Biology and Technology (AGBT) Conference (NASDAQ:NSTG)
us.rd.yahoo.com - February 16 at 6:25 PM
finance.yahoo.com logoHumana Issues Positive Coverage Decision for NanoString’s Prosigna® Breast Cancer Assay (NASDAQ:NSTG)
finance.yahoo.com - February 9 at 5:52 AM
4-traders.com logoNanoString Technologies : Humana Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay (NASDAQ:NSTG)
www.4-traders.com - January 31 at 7:51 PM
zacks.com logoWhat Makes Nanostring Technologies (NSTG) a Strong Sell? (NASDAQ:NSTG)
www.zacks.com - January 31 at 7:51 PM
4-traders.com logoNanoString Technologies : Combine Solicitation - reproducible and customized gene expression evaluation (NASDAQ:NSTG)
www.4-traders.com - January 30 at 8:56 AM
capitalcube.com logoNanoString Technologies, Inc. – Value Analysis (NASDAQ:NSTG) : January 12, 2017 (NASDAQ:NSTG)
www.capitalcube.com - January 12 at 7:32 PM
capitalcube.com logoNanoString Technologies, Inc. breached its 50 day moving average in a Bearish Manner : NSTG-US : January 11, 2017 (NASDAQ:NSTG)
www.capitalcube.com - January 11 at 7:30 PM
marketexclusive.com logoNanoString Technologies, Inc. (NASDAQ:NSTG) Files An 8-K Results of Operations and Financial Condition (NASDAQ:NSTG)
marketexclusive.com - January 11 at 12:47 AM
finance.yahoo.com logoNanoString Technologies Provides Preliminary Operational and Financial Results for 2016 (NASDAQ:NSTG)
in.finance.yahoo.com - January 10 at 8:56 AM
nasdaq.com logoBlue Cross Blue Shield Association Evidence Street Issues Positive Assessment for NanoString’s Prosigna® Breast Cancer Assay (NASDAQ:NSTG)
www.nasdaq.com - January 10 at 8:56 AM
streetinsider.com logoNanoString Technologies (NSTG) Receives Positive Assement For Prosigna Breast Cancer Assay (NASDAQ:NSTG)
www.streetinsider.com - January 10 at 8:56 AM
biz.yahoo.com logoNANOSTRING TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:NSTG)
biz.yahoo.com - January 10 at 8:56 AM
biz.yahoo.com logoPreliminary Q4 2016 NanoString Technologies Inc Operational and Earnings Release - Before Market Open (NASDAQ:NSTG)
biz.yahoo.com - January 10 at 8:56 AM
finance.yahoo.com logoQIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite (NASDAQ:NSTG)
finance.yahoo.com - January 10 at 8:55 AM
finance.yahoo.com logoIllumina (ILMN) Launches NovaSeq Series for $100 Genome (NASDAQ:NSTG)
finance.yahoo.com - January 10 at 8:55 AM
biz.yahoo.com logoNANOSTRING TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:NSTG)
biz.yahoo.com - January 6 at 7:36 PM
finance.yahoo.com logoNanoString Technologies to Present at J.P. Morgan 35th Annual Healthcare Conference (NASDAQ:NSTG)
finance.yahoo.com - December 22 at 7:13 PM
us.rd.yahoo.com logoIs Whitestone REIT (WSR) A Good Stock To Buy? (NASDAQ:NSTG)
us.rd.yahoo.com - December 15 at 7:50 PM
nasdaq.com logoProsigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested in Updated Analysis of (NASDAQ:NSTG)
www.nasdaq.com - December 13 at 12:01 AM
us.rd.yahoo.com logoProsigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested in Updated Analysis of TransATAC Study Presented at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium (NASDAQ:NSTG)
us.rd.yahoo.com - December 12 at 10:00 AM
insidermonkey.com logoNanoString Technologies Inc (NSTG): Are Hedge Funds Right About This Stock? (NASDAQ:NSTG)
www.insidermonkey.com - December 7 at 9:36 AM
us.rd.yahoo.com logo5:23 pm NanoString Technologies will present three oral presentations and fourteen posters covering Prosigna/PAM50 and other nCounter-based research at SABCS, which is being held December 6-10 (NASDAQ:NSTG)
us.rd.yahoo.com - December 6 at 11:39 PM
finance.yahoo.com logoNanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies … (NASDAQ:NSTG)
finance.yahoo.com - December 6 at 9:42 AM
finance.yahoo.com logoNanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium (NASDAQ:NSTG)
finance.yahoo.com - December 5 at 6:53 PM
finance.yahoo.com logoThe Scientist Magazine Names NanoString Technologies nCounter Vantage 3D Panels a Top 10 Innovation of 2016 (NASDAQ:NSTG)
finance.yahoo.com - December 1 at 6:48 PM
finance.yahoo.com logoNanoString Technologies Highlights Advances in Precision Oncology at the 58th Annual Meeting of the American Society of Hematology (NASDAQ:NSTG)
finance.yahoo.com - November 30 at 7:02 PM
News IconNew Study: NanoString Technologies, Inc. (NSTG) - Financial and Strategic SWOT Analysis Review (NASDAQ:NSTG)
reports.pr-inside.com - November 30 at 11:42 AM
finance.yahoo.com logoUPDATE – NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research (NASDAQ:NSTG)
finance.yahoo.com - November 11 at 6:15 PM
publicnow.com logoUPDATE - NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research (NASDAQ:NSTG)
www.publicnow.com - November 11 at 6:15 PM
finance.yahoo.com logoNANOSTRING TECHNOLOGIES INC Financials (NASDAQ:NSTG)
finance.yahoo.com - November 11 at 6:15 PM
publicnow.com logoNanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research (NASDAQ:NSTG)
www.publicnow.com - November 10 at 6:18 PM
capitalcube.com logoETF’s with exposure to NanoString Technologies, Inc. : November 8, 2016 (NASDAQ:NSTG)
www.capitalcube.com - November 8 at 6:12 PM
publicnow.com logoNanoString Launches Technology Access Program (TAP) for Transformative Platform for High-Plex Digital Spatial Profiling (NASDAQ:NSTG)
www.publicnow.com - November 7 at 7:11 PM
finance.yahoo.com logoEdited Transcript of NSTG earnings conference call or presentation 2-Nov-16 8:30pm GMT (NASDAQ:NSTG)
finance.yahoo.com - November 3 at 10:29 AM
capitalcube.com logoNanoString Technologies, Inc. breached its 50 day moving average in a Bearish Manner : NSTG-US : November 3, 2016 (NASDAQ:NSTG)
www.capitalcube.com - November 3 at 10:29 AM
nasdaq.com logoNanoString Technologies Releases Operating Results for Third Quarter of 2016 (NASDAQ:NSTG)
www.nasdaq.com - November 2 at 6:47 PM
sg.finance.yahoo.com logoNanoString reports 3Q loss (NASDAQ:NSTG)
sg.finance.yahoo.com - November 2 at 6:47 PM
biz.yahoo.com logoQ3 2016 NanoString Technologies Inc Earnings Release - After Market Close (NASDAQ:NSTG)
biz.yahoo.com - November 2 at 10:03 AM
streetinsider.com logoNanoString Technologies (NSTG) Issues Update on Hyb & Seq Platform at ASHG Annual Meeting (NASDAQ:NSTG)
www.streetinsider.com - October 19 at 6:48 PM
finance.yahoo.com logoNanoString Technologies Presents Update on Hyb & Seq™ Next-Generation Sequencing Chemistry at ASHG Annual Meeting (NASDAQ:NSTG)
finance.yahoo.com - October 19 at 11:34 AM
finance.yahoo.com logo6:02 am NanoString Technologies updates on its Hyb & Seq platform which is currently in development; 'We're making excellent progress and plan to provide our next status report at AGBT 2017 in February' (NASDAQ:NSTG)
finance.yahoo.com - October 19 at 11:34 AM
publicnow.com logoNanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples (NASDAQ:NSTG)
www.publicnow.com - October 18 at 11:46 AM
publicnow.com logoNanoString Technologies to Release Third Quarter 2016 Financial Results and Host Conference Call on Wednesday, November 2, 2016 (NASDAQ:NSTG)
www.publicnow.com - October 5 at 11:42 AM
capitalcube.com logoETF’s with exposure to NanoString Technologies, Inc. : September 30, 2016 (NASDAQ:NSTG)
www.capitalcube.com - September 30 at 11:43 AM

Social

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

Where is NanoString Technologies' stock going? Where will NanoString Technologies' stock price be in 2017?

4 brokerages have issued twelve-month target prices for NanoString Technologies' stock. Their forecasts range from $20.00 to $21.00. On average, they expect NanoString Technologies' stock price to reach $20.50 in the next year.

When will NanoString Technologies announce their earnings?

NanoString Technologies is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

What are analysts saying about NanoString Technologies stock?

Here are some recent quotes from research analysts about NanoString Technologies stock:

  • According to Zacks Investment Research, "NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington. " (1/18/2017)

  • BTIG Research analysts commented, "During the past several days at the American Association for Cancer Research (AACR) conference we visited the NanoString booth, and also had the chance to speak with the CEO, CFO and CSO while reviewing a new technology for immunohistochemistry profiling. The collective NSTG technology effort within immuno-oncology continues to broaden and differentiate, and we think that the increasing mindshare of NSTG technology within the cancer research community is correlating with strong booth traffic at the AACR conference. We reiterate our Buy rating and $20 Price Target." (4/20/2016)

Who owns NanoString Technologies stock?

NanoString Technologies' stock is owned by many different of retail and institutional investors. Top institutional investors include Foresite Capital Management II LLC (3.23%), DSC Advisors L.P. (2.21%), Foresite Capital Management III LLC (2.09%), Renaissance Technologies LLC (1.14%), State Street Corp (1.06%) and Fred Alger Management Inc. (0.76%). Company insiders that own NanoString Technologies stock include Barney Saunders, Charles P Waite Jr, David W Ghesquiere, James A Johnson, R Bradley Gray and Wayne Burns.

Who sold NanoString Technologies stock? Who is selling NanoString Technologies stock?

NanoString Technologies' stock was sold by a variety of institutional investors in the last quarter, including Deerfield Management Co., Foresite Capital Management II LLC, Foresite Capital Management III LLC, Levin Capital Strategies L.P., Nicholas Investment Partners LP, TCW Group Inc. and First Light Asset Management LLC. Company insiders that have sold NanoString Technologies stock in the last year include Barney Saunders, Charles P Waite Jr, David W Ghesquiere, James A Johnson, R Bradley Gray and Wayne Burns.

Who bought NanoString Technologies stock? Who is buying NanoString Technologies stock?

NanoString Technologies' stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Fred Alger Management Inc., Marshall Wace LLP, Numeric Investors LLC, Russell Investments Group Ltd., Bogle Investment Management L P DE, Oxford Asset Management and Two Sigma Investments LP.

How do I buy NanoString Technologies stock?

Shares of NanoString Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of NanoString Technologies stock cost?

One share of NanoString Technologies stock can currently be purchased for approximately $18.83.

NanoString Technologies (NASDAQ:NSTG) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Earnings History Chart

Earnings by Quarter for NanoString Technologies (NASDAQ:NSTG)

Dividend History Chart

Dividend Payments by Quarter for NanoString Technologies (NASDAQ:NSTG)

Last Updated on 2/25/2017 by MarketBeat.com Staff